"CD24 as a Novel Predictive Biomarker in Patients with Hepatocellular Carcinoma: Friend or Foe?." Journal of Investigative Surgery, 33(6), pp. 542–543
This article refers to:
Journal of Investigative Surgery
Volume 33, 2020 - Issue 6
Commentary
CD24 as a Novel Predictive Biomarker in Patients with Hepatocellular Carcinoma: Friend or Foe?
Nikolaos Machairas3rd Department of Surgery, National and Kapodistrian University of Athens, Medical School, Athens, Greece; Correspondence[email protected]
http://orcid.org/0000-0003-3239-3905
, MD, PhDhttp://orcid.org/0000-0003-3239-3905, Diamantis I. Tsilimigras3rd Department of Surgery, National and Kapodistrian University of Athens, Medical School, Athens, Greece; http://orcid.org/0000-0002-3676-9263
, MDhttp://orcid.org/0000-0002-3676-9263 & Demetrios MorisDepartment of Surgery, Duke University Medical Center, Durham, North Carolina, USAhttp://orcid.org/0000-0002-5276-0699
, MD, PhDhttp://orcid.org/0000-0002-5276-0699![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})